Moderna’s COVID-19 vaccine candidate set for final testing in the US
July 15, 2020Research and Development COVID-19, coronavirus
The first COVID-19 vaccine being used in clinical trials in the US is set to begin final testing. The experimental …
Pharmafile.com’s weekly COVID-19 news round-up
July 15, 2020Research and Development COVID-19, coronavirus, vaccines
The coronavirus news this week focuses on therapeutics, with Gilead’s remdesivir reducing the risk of death in 62% of severe …
People in England must wear face mask in shops from 24 July
July 14, 2020Manufacturing and Production coronavirus, masks
Face masks are set to become mandatory in shops across England beginning on 24 July, following months of mixed messaging …
Malaria prophylactic tafenoquine shows antiviral activity against SARS-CoV-2 in cell cultures
July 14, 2020Manufacturing and Production, Research and Development 60 Degrees Pharmaceuticals, COVID-19, coronavirus, pharma
Specialist tropical disease drug firm 60 Degrees Pharmaceuticals has revealed that its therapy Arakoda (tafenoquine) has been shown in cell …
Arthritis drug reduces COVID-19 deaths for patients on ventilators
July 14, 2020Manufacturing and Production COVID-19, coronavirus
The rheumatoid arthritis drug tocilizumab reduces death rates in coronavirus patients on ventilation, according to new studies.
Roche and Blueprint extend collaboration with $1.7 billion cancer drug development and commercialisation deal
July 14, 2020Manufacturing and Production, Research and Development Blueprint Medicines, Cancer, Roche, pralsetinib
Roche and Blueprint Medicines have come together in a $1.7 billion development and commercialisation partnership focused on precision therapy pralsetinib …
Pfizer and BioNTech’s COVID-19 vaccines to have their development fast tracked by the FDA
July 14, 2020Manufacturing and Production, Research and Development COVID-19, Vaccine, coronavirus
The FDA has granted Pfizer and BioNTech’s COVID-19 vaccine candidates Fast Track status to speed up their development and review. …
Itolizumab “significantly reduced mortality” in hospitalised COVID-19 patients with respiratory distress, secures emergency use authorisation in India
July 13, 2020Research and Development, Sales and Marketing COVID-19, Itolizumab, coronavirus
Itolizumab, a drug currently being developed by biotech firm Equillium for autoimmune and inflammatory disorders, “significantly reduced mortality” in hospitalised …
WHO reports record daily increase in global COVID-19 cases
July 13, 2020Sales and Marketing COVID-19, coronavirus
The World Health Organization reported the largest daily increase in COVID-19 cases since the pandemic began. Over the weekend there …
Russia claims it has completed the first human trial for COVID-19 vaccine
July 13, 2020Sales and Marketing COVID-19, coronavirus, vaccines
Russia has become the first country to complete a COVID-19 vaccine trial on humans, according to the Russian News Agency. …
Remdesivir cuts death risk by 62% in coronavirus patients, new study shows
July 13, 2020Sales and Marketing COVID-19, coronavirus
Gilead’s remdesivir reduced the risk of death in 62% of severe COVID-19 patients, according to a new study. The company …
Roche’s Tecentriq fails to hit main Phase 3 goal in front-line ovarian cancer
July 13, 2020Research and Development, Sales and Marketing Genentech, Roche, ovarian cancer, tecentriq
Roche subsidiary Genentech has revealed that its immunotherapy Tecentriq (atezolizumab), combined with Avastin (bevacizumab), paclitaxel and carboplatin, fell short of …
Dr Edwin Moses appointed as Chairman of the Board of Sensorin
July 10, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Sensorin have appointed Dr Edwin Moses as the Chairman of its Board of Directors Moses joins from his previous role …
New data shows Gilead’s remdesivir “potently inhibited” SARS-CoV-2 in human lung cell cultures
July 10, 2020Medical Communications, Research and Development COVID-19, Gilead, coronavirus, remdesivir
New findings published from researchers at Vanderbilt University Medical Center (VUMC) at the University of North Carolina, as well as …
Scientists warn of brain damage linked to COVID-19
July 10, 2020Medical Communications COVID-19, Neurological, coronavirus
COVID-19 could lead to a wave of brain damage in people who were infected with the virus. Experts at the …
Industry comes together to form the AMR Action Fund, pledging $1bn to fight antimicrobial resistance
July 10, 2020Medical Communications, Research and Development AMR, antimicrobial resistance, biotech, pharma
Over 20 biopharma firms have come together to launch the AMR Action Fund, an initiative of the International Federation of …
The World Health Organization says COVID-19 can linger in the air indoors
July 10, 2020Medical Communications COVID, COVID-19, WHO, coronavirus
The World Health Organization has recoginised that COVID-19 can be transmitted indoors by droplets in the air, reversing its previous …
Top Ten most popular articles on Pharmafile.com this week
July 10, 2020Medical Communications coronavirus, covid19, top 10
The World Health Organization features prominently in the news this week, as it discontinued trials into the viability of hydroxychloroquine, …
J&J under fire from 170 nonprofits to halt baby powder sales worldwide because it contains asbestos
July 9, 2020Sales and Marketing Cancer, J&J, JJ, pharma, talc
In the latest chapter in Johnson & Johnson’s talc-related woes, the company is being pressured by group of over 170 …
NICE recommends Takeda’s Adcetris for previously untreated systemic anaplastic large cell lymphoma
July 9, 2020Sales and Marketing Adcentris, NICE, Takeda, UK
NICE has announced it has recommended Takeda’s Adcetris (brentuximab vedotin), in combination with cyclophosphamide, doxorubicin and prednisone (CHP), for use …
Latest content
The evidence bar impacting UK medical cannabis access
Addressing the rheumatic disease diagnostic gap in primary care
